Angelman Syndrome Foundation Canada
Cart 0
Walk Walk Resources News Contact Donate Donate Now
CLINICS ASF Canada Family Fund
About Angelman Syndrome AS Clinical Care Toolkit
ASF Events Launch Event IAD 2024 IAD Resources HUG Camp
Newsletter March 2023 Newsletter April 2023 Newsletter May 2023 Newsletter July 2023 Newsletter September 2023 Newsletter October 2023 Newsletter November 2023
About ASF Canada Board of Directors Executive Director Get Involved Board Member Recruitment
Cart 0
WalkWalk ResourcesNewsContactDonateDonate Now
Angelman Syndrome Foundation Canada
Keeping Families Strong
What is Angelman Syndrome About Angelman Syndrome AS Clinical Care Toolkit CLINICS Events ASF Events Launch Event IAD 2024 IAD Resources HUG Camp Newsletters Newsletter March 2023 Newsletter April 2023 Newsletter May 2023 Newsletter July 2023 Newsletter September 2023 Newsletter October 2023 Newsletter November 2023 About Us About ASF Canada Board of Directors Executive Director Get Involved Board Member Recruitment ASF Canada Family Fund

First Angelman person in Canada to get first dose in phase 1 of the GeneTx and Ultragenyx clinical trial.

Learn more
Guest UserOctober 7, 2021
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

New Board of Director Position for CASS!

Volunteer PositionsGuest UserNovember 19, 2021
Next

GTX-102 for Angelman syndrome Feasibility Questionnaire

Guest UserApril 15, 2021

Angelman Syndrome Foundation Canada

Registered Charity: 888455847RR0001

PO Box 32102 RPO Millwoods
Edmonton, AB
T6K 4C2
Canada

executive.director@angelmancanada.org

Info

Sign up to receive news and updates.

Thank you!
Angelman Syndrome Foundation Canada
PO Box 31092 Namao Centre ,
Edmonton AB T5Z 3P3,
Canada
executive.director@angelmancanada.org
Hours
Mon 8am to 9pm
Tue 8am to 9pm
Wed 8am to 9pm
Thu 8am to 9pm
Fri 8am to 9pm
Sat 8am to 9pm
Sun 8am to 9pm